Altabax and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is reported as a side effect among people who take Altabax (retapamulin), especially for people who are female, 60+ old, also take Coumadin, and have Infection.
The phase IV clinical study analyzes which people have Weakness when taking Altabax. It is created by eHealthMe based on reports of 749 people who have side effects when taking Altabax from the FDA, and is updated regularly.
What is Altabax?
Altabax has active ingredients of retapamulin. eHealthMe is studying from 753 Altabax users. Check the latest studies of Altabax.
What is Weakness?
Weakness is found to be associated with 3,641 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.
749 people reported to have side effects when taking Altabax.
Among them, 13 people (1.74%) have Weakness.

Among these 13 people:
What is the gender of people who have Weakness when taking Altabax? *
- female: 58.33 %
- male: 41.67 %
What is the age of people who have Weakness when taking Altabax? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 8.33 %
- 50-59: 8.33 %
- 60+: 83.33 %
What are other drugs people take besides Altabax? *
- Coumadin: 9 people, 69.23%
- Aredia: 6 people, 46.15%
- Cymbalta: 6 people, 46.15%
- Lisinopril: 6 people, 46.15%
- Revlimid: 6 people, 46.15%
- Dexamethasone: 6 people, 46.15%
- Synthroid: 6 people, 46.15%
- Zometa: 6 people, 46.15%
- Velcade: 6 people, 46.15%
- Alkeran: 6 people, 46.15%
What are other side effects people have besides Weakness? *
- Acute Kidney Failure: 10 people, 76.92%
- Pneumonia: 10 people, 76.92%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 7 people, 53.85%
- Urinary Tract Infection: 7 people, 53.85%
- Deformity (disfigurement): 7 people, 53.85%
- Fall: 7 people, 53.85%
- Weight Decreased: 6 people, 46.15%
- Exostosis (formation of new bone on the surface of a bone): 6 people, 46.15%
- Fungal Infection: 6 people, 46.15%
- Herpes Zoster: 6 people, 46.15%
What are the existing conditions these people have? *
- Pemphigoid (tense blisters on the skin): 1 person, 7.69%
- Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
- Infection: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Altabax and have Weakness?
- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Altabax:
- Altabax (753 reports)
Weakness treatments and more:
- Weakness (586,876 reports)
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of retapamulin:
- Weakness and drugs with ingredients of retapamulin (26 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Altabax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Weakness:
- Weakness (3,641 drugs)
Browse all the conditions that are associated with Weakness:
- Weakness (6,612 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on retapamulin (the active ingredients of Altabax) and Altabax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Glipizide cause Drug Hypersensitivity? - now
- Could Cytarabine cause Pelvic Pain? - a second ago
- Drug interactions of Xopenex and Miconazole Nitrate - 5 seconds ago
- Could Morphine cause Amyotrophy? - 11 seconds ago
- Could Topicort cause Nausea? - 14 seconds ago
- Drug interactions of Sulfasalazine and Sodium Bicarbonate - 15 seconds ago
- Could Calcium Carbonate cause Joint Effusion? - 17 seconds ago
- Drug interactions of Emtricitabine and Bortezomib - 17 seconds ago
- Drug interactions of Sulfasalazine and Fesoterodine Fumarate - 21 seconds ago
- Drug interactions of Tylenol W/ Codeine No. 3 and Lovaza - 24 seconds ago